AMRX Amneal Pharmaceuticals · $17.85 Extended — don't chase; wait for a pullback过度拉升 — 勿追高；等待回撤 Terminal终端 ↗

All coverage所有股票 · Health Care

Amneal Pharmaceuticals · Health Care

AMRX

$17.85
Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products.AmnealPharmaceuticals,Inc.是一家美国上市制药公司，从事仿制药和特色药品的开发、制造和分销。
Rate-sensitive利率敏感 Mid cap中盘 $6B
Engine stance引擎立场2026-07-20
Extended — don't chase; wait for a pullback过度拉升 — 勿追高；等待回撤
You missed the bottoming entry — the low already formed and price is now extended (overbought (daily RSI 69, 3-day 74 & 已错过筑底入场——低点已经形成，目前价格已拉伸（已超买（日线 RSI 69、3 日 74 与周线 73））。不要追高；等待回调至 10 日均线或下一个周期低点。若已持有则继续持有。
Open in Terminal打开终端 ↗ All coverage所有股票 Data through数据截至 2026-07-20 · regenerated nightly每日更新

Key Statistics关键统计

Price价格
$17.85
1.1% below 52-week high低于52周高点 1.1%
Market Cap市值
$6B
Normal volume正常成交量
P/E Ratio市盈率
77.9x
28.9x sector median
Beta贝塔
0.73
Moves about 0.7x the market波动幅度约为市场的 0.7 倍
RSI (14)RSI（14）
69
Elevated偏高
Next Earnings下次财报
2026-08-04 (16d)
Volatility Rank波动率分位
56th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
2.5% of float

Performance价格表现

Period周期 AMRX S&P 500vs Index对比指数
1 Week近1周 +4.9% -1.5% Beat the index by 6.4 points跑赢指数 6.4 个百分点
1 Month近1月 +9.6% +0.6% Beat the index by 9.0 points跑赢指数 9.0 个百分点
3 Months近3月 +28.3% +4.7% Beat the index by 23.6 points跑赢指数 23.6 个百分点
6 Months近6月 +33.1% +7.8% Beat the index by 25.3 points跑赢指数 25.3 个百分点
Year to date年初至今 +41.0% +9.1% Beat the index by 31.9 points跑赢指数 31.9 个百分点
1 Year近1年 +116.6% +19.4% Beat the index by 97.2 points跑赢指数 97.2 个百分点
3 Years近3年 +450.9% +69.4% Beat the index by 381.5 points跑赢指数 381.5 个百分点

Technicals技术面

RSI (14)RSI（14） 69 Elevated偏高
vs 50-day相对50日均线 +19.5% vs 50-day avg
vs 200-day相对200日均线 +36.4% vs 200-day avg
Volatility rank波动率分位 56th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$17.13
Don't chase above不追高于
$17.85
Stop止损
$16.11
Extended — wait for a pullback过度拉伸 — 等待回撤

Earnings财务业绩

16
days until next report天后公布财报
2026-08-04

Estimates being cut预期下调

Earnings call transcripts — coming soon财报电话会议记录 — 即将上线

Valuation估值

Multiple指标 AMRX Sector median行业中位 Cheaper than相对便宜
P/E (trailing)市盈率（历史） 77.94x 28.92
11%
P/S市销率 1.86x 3.02
68%
Earnings yield盈利收益率 1.28% 2.72
34%
FCF yield自由现金流收益率 4.81% 3.94
60%
EV/EBITDA企业价值/EBITDA 17.51x 18.21
53%
P/FCF市值/自由现金流 20.81x 22.42
53%
Analyst price targets — coming soon分析师目标价 — 即将上线

Financials财务数据

Revenue营业收入
$2.0B
2020
$2.1B
2021
$2.2B
2022
$2.4B
2023
$2.8B
2024
$3.0B
2025
5yr CAGR5年复合增速: 8.7%
Earnings Per Share每股收益
$0.61
2020
$0.07
2021
$-0.86
2022
$-0.48
2023
$-0.38
2024
$0.22
2025
5yr CAGR5年复合增速: -18.5%
Free Cash Flow自由现金流
$322.6M
2020
$194.1M
2021
$18.7M
2022
$302.4M
2023
$243.2M
2024
$269.9M
2025
Margins利润率
Gross margin毛利率
36.9%
Operating margin营业利润率
13.1%
Net margin净利率
2.4%
FCF margin自由现金流利润率
11.3%
-101.8%Return on Equity股本回报率
2.0%Return on Assets资产回报率
Leverage杠杆
Net debt / EBITDA净债务/EBITDA5.07
Current ratio流动比率2.17
Capital Allocation资本配置
Stock-based comp股权薪酬$32.0M
Share count change (1y)股数变化（1年）+1.5%
Piotroski皮奥特罗斯基 7/8 Altman Z阿尔特曼Z: grey (2.2) Clean稳健

Snapshot Gauges综合指标

Valuation vs Sector估值相对行业
Roughly fair vs sector相对行业估值合理
Cheaper than 48% of its sector on blended multiples综合估值倍数低于行业内 48% 的公司
Beta市场敏感度
0.73×
0.21×3×
Moves about 0.7× the market波动幅度约为市场的 0.7 倍
Financial Health财务健康
7/8
Altman阿尔特曼: grey
Strong financial health财务健康状况良好
Dividend分红
—
Does not pay a dividend不派发股息

Why Is It Moving为何波动

News新闻 1 recent stories — mixed1 篇最新报道，多空参半
Macro宏观 Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓 Insider cluster activity内部人集中交易
Technical技术面 AMRX made a new 52-week highAMRX 创52周新高

Ownership & Smart Money持仓与聪明钱

Insider activity内部人员活动: -$2.2M net (0 buyers, 2 sellers)-$2.2M 净值（0 买家，2 卖家）

Signal History信号历史

BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS. A daily bottoming setup did fire (swing low in, momentum turned up), but it's LATE — price is already extended above the cycle low (formed ~18 day(s) ago @ 16.11) and overbought (daily RSI 69, 3-day 74 & weekly 73). A momentum cross is a LAGGING confirmation: after a vertical run it only triggers once the move is mature, so the bottoming entry has already passed. This is a chase, not a fresh buy止盈。日线筑底形态确实已经触发（摆动低点出现、动量转向上行），但为时已晚——价格已显著高于周期低点（约 18 天前形成 @ 16.11）且已超买（日线 RSI 69、3 日 74 与周线 73）。动量交叉属于滞后确认：在垂直拉升之后，只有当走势已经成熟时才会触发，因此筑底入场早已错过。这是追高，而非新的买入
TOP WATCH NEARING A HIGH
Jul 16, 2026
AMRX made a new 52-week highAMRX 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $18.04.价格创出52周新高 — 全市场关注的动量/趋势极值。$18.04。
Jul 16, 2026
AMRX StochRSI turned up from oversoldAMRX StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $18.04.StochRSI重回20上方 — 下行动量趋缓的最早预警。$18.04。
Jul 16, 2026
AMRX RSI reached overboughtAMRX RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $18.04.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$18.04。
Jul 15, 2026
AMRX took relative-strength leadershipAMRX 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $17.20.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$17.20。
Jul 14, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 13, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 13, 2026
AMRX took relative-strength leadershipAMRX 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $17.18.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$17.18。
Jul 13, 2026
AMRX RSI reached overboughtAMRX RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $17.18.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$17.18。
Jul 7, 2026
AMRX RSI reached overboughtAMRX RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $17.05.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$17.05。
Jul 6, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 6, 2026
AMRX daily MACD crossed downAMRX 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $16.92.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$16.92。
Jun 30, 2026
AMRX made a new 52-week highAMRX 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $17.31.价格创出52周新高 — 全市场关注的动量/趋势极值。$17.31。

Showing last 15 of显示最近15条，共 259 signals条信号

Factor Profile因子特征

Composite factor score综合因子得分: -0.44
Value价值
-0.9
Profitability盈利能力
-0.1
Quality质量
-1.8
Investment资本投入
+0.2
Low volatility低波动
+0.4
Low market beta低市场敏感度
+0.2
Earnings quality盈利质量
+0.5
Short interest空头兴趣
+0.7

Company Profile公司档案

Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products.AmnealPharmaceuticals,Inc.是一家美国上市制药公司，从事仿制药和特色药品的开发、制造和分销。

Recent News最新动态

Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations GlobeNewswire Inc. 2026-07-17
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。
Open Analyzer打开分析器 Browse All Stocks浏览所有股票